{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:00:51Z","timestamp":1783443651337,"version":"3.54.6"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["200110"],"award-info":[{"award-number":["200110"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.msard.2020.102536","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T16:18:56Z","timestamp":1601309936000},"page":"102536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Could the performance of oral glucose tolerance test contribute to the brain health-focused care in multiple sclerosis?"],"prefix":"10.1016","volume":"46","author":[{"given":"Gorica","family":"Maric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Lalic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Pekmezovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Tamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Rajkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Rasulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarlota","family":"Mesaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Drulovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2020.102536_bib0001","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/193229681300700112","article-title":"A novel fasting blood test for insulin resistance and prediabetes","volume":"7","author":"Cobb","year":"2013","journal-title":"J. Diabetes. Sci. Technol."},{"key":"10.1016\/j.msard.2020.102536_bib0003","first-page":"247","article-title":"Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action","volume":"7","author":"Damal","year":"2013","journal-title":"Biologics"},{"key":"10.1016\/j.msard.2020.102536_bib0004","series-title":"Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of A WHO\/IDF Consultation","year":"2006"},{"key":"10.1016\/j.msard.2020.102536_bib0006","doi-asserted-by":"crossref","first-page":"e10883","DOI":"10.1371\/journal.pone.0010883","article-title":"\u03b1-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population","volume":"5","author":"Gall","year":"2010","journal-title":"PLoS. One."},{"key":"10.1016\/j.msard.2020.102536_bib0008","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1756285610385608","article-title":"Evolving expectations around early management of multiple sclerosis. Ther","volume":"3","author":"Gold","year":"2010","journal-title":"Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2020.102536_bib0009","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1177\/1352458518809326","article-title":"International consensus on quality standards for brain health-focused care in multiple sclerosis","volume":"25","author":"Hobart","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2020.102536_bib0010","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102536_bib0011","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/1570161114666160905170644","article-title":"Impaired Insulin Sensitivity and Secretion in Patients with Alzheimer's Disease: The Relationship with Other Atherosclerosis Risk Factors","volume":"15","author":"Macesic","year":"2017","journal-title":"Curr.Vasc. Pharmacol."},{"key":"10.1016\/j.msard.2020.102536_bib0012","doi-asserted-by":"crossref","first-page":"e43675","DOI":"10.1371\/journal.pone.0043675","article-title":"Is metabolic flexibility altered in multiple sclerosis patients?","volume":"7","author":"Mahler","year":"2012","journal-title":"PLoS. One."},{"key":"10.1016\/j.msard.2020.102536_bib0013","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fneur.2014.00250","article-title":"Perturbed glucose metabolism: insights into multiple sclerosis pathogenesis","volume":"5","author":"Mathur","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2020.102536_bib0014","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0404.1982.tb06856.x","article-title":"Age at onset, initial symptomatology and course of multiple sclerosis","volume":"66","author":"Poser","year":"1982","journal-title":"Acta. Neurol. Scand."},{"key":"10.1016\/j.msard.2020.102536_bib0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nut.2013.08.001","article-title":"Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress","volume":"30","author":"Oliveira","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.msard.2020.102536_bib0016","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11011-015-9665-1","article-title":"Hyperinsulinemia in newly diagnosed patients with multiple sclerosis","volume":"30","author":"Penesova","year":"2015","journal-title":"Metab. Brain. Dis."},{"key":"10.1016\/j.msard.2020.102536_bib0017","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/0929867324666161123093606","article-title":"Lipids at the Cross-road of Autoimmunity in Multiple Sclerosis","volume":"24","author":"Reale","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.msard.2020.102536_bib0018","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102536_bib0019","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.msard.2018.08.014","article-title":"Metabolomic profile of insulin resistance in patients with multiple sclerosis is associated to the severity of the disease","volume":"25","author":"Ruiz-Arg\u00fcelles","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2020.102536_bib0020","first-page":"315","article-title":"Inflammasomes in neuroinflammation and changes in brain function: a focused review","volume":"8","author":"Singha","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.msard.2020.102536_bib0021","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41983-020-0155-y","article-title":"Impact of insulin resistance and metabolic syndrome on disability in patients with multiple sclerosis","volume":"56","author":"Soliman","year":"2020","journal-title":"Egypt. J. Neurol. Psychiatry. Neurosurg."},{"key":"10.1016\/j.msard.2020.102536_bib0022","series-title":"The WHO STEPwise approach to noncommunicable disease risk factor surveillance: Guide to Physical Measurements (Step 2)","year":"2017"},{"key":"10.1016\/j.msard.2020.102536_bib0023","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.msard.2020.102536_bib0024","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2005.08.017","article-title":"Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis","volume":"245","author":"Watson","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2020.102536_bib0025","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/1352458513515957","article-title":"Does multiple sclerosis affect glucose tolerance?","volume":"20","author":"Wens","year":"2014","journal-title":"Mult. Scler."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820306106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820306106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:56:54Z","timestamp":1761901014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820306106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":22,"alternative-id":["S2211034820306106"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102536","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could the performance of oral glucose tolerance test contribute to the brain health-focused care in multiple sclerosis?","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102536"}}